Why your laundry could be making you sick and what to do about it
Tossing in a load of wash at home sounds ordinary and harmless.
But healthcare professionals who wash their work uniforms at home may be unknowingly spreading superbugs, according to a new study.
Professor Katie Laird of De Montfort University Leicester, a public university in England, tested home washing machines in a study and found the machines failed to remove potentially harmful material, even after running a hot water setting at the equivalent of 140 degrees Fahrenheit.
Shampoo Recalled For Bacteria Contamination That Could Cause Infection
"Our research highlights that domestic laundering of healthcare textiles may not consistently eliminate harmful bacteria, including antibiotic-resistant bacteria," Laird told Fox News Digital.
The team tested six different models of washing machines to see how well they cleaned fabric contaminated with bacteria that can cause a variety of health conditions.
Read On The Fox News App
Half of the machines did not disinfect the clothing during a rapid cycle — while a third of them failed to clean sufficiently during the standard cycle.
Laird, a professor of microbiology in the School of Pharmacy and head of the university's Infectious Disease Research Group, said the finding "highlights potential risks associated with laundering healthcare uniforms at home, particularly concerning the spread of antimicrobial resistance (AMR) within community and hospital settings."
A Common Killer Bug Is Endangering Americans: 'Pandemic In Plain Sight'
In addition, this could mean home washing machines are a hub for antibiotic-resistant bacteria.
Domestic detergents could even potentially create antibiotic-resistant strains of bacteria, according to Laird.
Even if healthcare workers followed all washing guidelines, half the machines in the study didn't reach the correct temperature, the study found.
"What this means is that even if healthcare workers are following all the guidelines to domestically wash their uniforms, they will still not be reaching the disinfection level required to remove all pathogenic bacteria," the professor said.
The study was conducted with non-healthcare personnel, so the bacteria on that clothing may differ from the clothing of those who work in healthcare settings.
New Class Of Antibiotics Discovered: 'Promising Answer'
Potentially, however, the latter would see higher levels of "pathogenic and antibiotic resistant strains in healthcare workers' domestic washing machines," the professor said.
Laird recommended that healthcare professionals and their institutions re-evaluate policies that allow workers to wash their work clothing at home.
For more Health articles, visit www.foxnews.com/health
"Implementing standardized in-house laundering within healthcare facilities or using external industrial laundries will enhance infection control measures," she said.
Due to at-home machines not functioning as they should, per the study, the research team recommended using a disinfectant for those washing machines at least once a month.
Click Here To Sign Up For Our Health Newsletter
They also recommended doing an empty wash in the machine to disinfect it at a temperature of approximately 194 degrees Fahrenheit.
"For individuals laundering at home, it's crucial to adhere strictly to guidelines, such as using appropriate temperatures and detergents, to minimize risks," Laird told Fox News Digital.
The team also said that effective laundering practices are a critical component, but that these should be part of a multifaceted approach.
They should "includ[e] prudent antibiotic use, robust infection control measures, and public education on hygiene practices and antimicrobial resistance," she said.Original article source: Why your laundry could be making you sick and what to do about it
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
2 hours ago
- Axios
Starbucks taps into health trends with protein coffee test
LAS VEGAS — Starbucks is tapping into the growing demand for protein-packed drinks as consumers seek to boost their intake for health and wellness. Why it matters: The world's largest coffee chain unveiled Tuesday that it is testing protein in its cold foam as part of its "Back to Starbucks" plan. CEO Brian Niccol is trying to reverse a decline in foot traffic and sales by returning to its roots. The big picture: Protein is hot and having a moment beyond social media influencers sharing order hacks. Restaurant brands like Dutch Bros Coffee and Smoothie King have added more protein to their products to cater to changing consumer appetites. Eating a high-protein diet is important to maintain muscle for people taking appetite-suppressing injectable treatments like Ozempic and Wegovy, research shows. Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029, according to investment bank UBS. Zoom in: Niccol told Axios in an interview Tuesday that the protein cold foam being tested is for a number of different consumer groups including 20-year-old males, 50-year-old females and people taking GLP-1s. "I was watching people coming to our stores, they would get three shots of espresso over ice," Niccol said. "And in some cases, they pull their own protein powder out of their bag, or in other cases, they have a protein drink, like a Fair Life and they'd pour that into their drink." "I'm like, well, wait a second, we can make this experience better for them," he said. "The good news is now I think we're right on trend, and we can do it I think arguably better than anybody else." Flashback: Starbucks had protein smoothies in the past and launched its Vivanno shakes in 2008. They were discontinued in 2018. The company also launched a protein drink in the U.K. last year. The intrigue: Starbucks said the protein powder should be able to be added to any of its cold foam flavors. What's next: Starbucks is testing protein cold foam in five locations in the U.S. under its Starting Five model.
Politico
2 hours ago
- Politico
There's one vice RFK Jr. isn't talking about
Robert F. Kennedy Jr. has made it his mission to remind Americans that they need to get off the couch and lay off the junk food. But there's one vice he's not talking about: smoking. That's troubled anti-smoking activists, researchers who focus on the diseases tobacco causes and Democrats in Congress who point out that smoking, despite a marked decline in recent years, still leads to more preventable deaths than anything else. Even so, Kennedy didn't mention the health impacts of smoking once in last month's Make America Healthy Again report assessing the biggest threats to Americans' health. That marks a turning point from the priorities of public health officials going back decades, including the Biden administration's, which targeted smoking as part of a moonshot plan to halve cancer death rates. Anti-tobacco advocates fear deemphasizing the dangers of tobacco could slow or even halt progress in driving down smoking rates. 'Attempting to combat chronic disease without tobacco control is like attempting a triathlon without a bicycle,' said Brian King, whom Kennedy pushed out of his job as the Food and Drug Administration's top tobacco regulator in April. 'You're destined for failure before leaving the starting line.' Since President Donald Trump's inauguration, his health agencies appear to have shelved two moves King planned to combat smoking, banning the last remaining legal cigarette flavoring, menthol, and requiring companies to reduce the amount of nicotine in their products. Nicotine is what makes cigarettes addictive. But an HHS spokesperson said the department 'remains steadfast in its mission to protect and promote public health,' adding that the MAHA report is not an 'exhaustive inventory of every HHS program or public health challenge.' 'HHS agencies continue to carry out their responsibilities, including work on tobacco control, with the highest level of integrity and commitment to the American public,' the spokesperson said. A sustained public health campaign to educate Americans about smoking's risks over decades has driven a huge decrease in use. In the 1960s, more than 4 in 10 adults smoked cigarettes. Now it's fewer than 1 in 8. And the public health success among kids is even starker. Fewer than 1 in 26 now smoke cigarettes, according to an analysis of federal data. The negative health impacts of tobacco use are well-studied and vast. For years it has been the top preventable cause of death in the United States, contributing to cancer, heart disease and stroke. But when Sen. Dick Durbin (D-Ill.) quizzed Kennedy about that during a budget hearing last month, asking him to name the 'No. 1 cause of preventable death in America today,' Kennedy was stumped. 'I'm not sure what you're talking about,' he said. Kennedy's apparent lack of interest in combating smoking — the word 'tobacco' appears in the MAHA report only within the context of his concerns about food marketing while 'smoking' and 'cigarettes' are never mentioned — also suggests this Trump administration won't be like the first. Then, Trump's FDA commissioner, Scott Gottlieb, put the menthol ban and the limits on nicotine on the table, drawing applause from anti-smoking activists. Congress permitted the agency to make those moves in a 2009 law. That law banned flavorings except menthol — which is a cash cow for Marlboro cigarette maker Philip Morris, whose support helped get the law passed — but gave the FDA the power to decide whether to ban it. It also gave the agency the power to force cigarette companies to reduce nicotine levels. The Obama administration didn't do so. President Joe Biden proposed limiting nicotine levels after the 2024 election but never finalized the rule. A Biden plan to ban menthol cigarettes in 2022 was also not finalized. Menthol is popular among Black smokers and some Democrats feared a ban could alienate crucial voters in a presidential election year. Jerome Adams, who was surgeon general during the first Trump term, said he wants Kennedy to prioritize the tobacco regulations laid out in Gottlieb's tobacco regulation plan — an effort he said would benefit youth and marginalized communities that are disproportionately impacted by menthol cigarettes. 'These proposed regulations align with the MAHA movement's focus on preventing chronic diseases,' Adams said. The tobacco industry spent heavily on Trump's 2024 campaign — and already has a lot to show for it. Trump pledged to 'save' vaping on his social media site, Truth Social, in September after meeting with Vapor Technology Association Executive Director Tony Abboud. The Trump administration pushed King — whom the tobacco industry had criticized for years — out of his job leading the FDA's Center for Tobacco Products. Job dismissals led by Trump's Department of Government Efficiency also gutted the CDC Office on Smoking and Health, which oversees federal smoking cessation programs and studies. The Trump administration also slashed funds the National Institutes of Health disburses to research facilities, which scientists say could imperil tobacco smoking studies. Asked about the industry's contributions to the Trump campaign, White House spokesperson Kush Desai wrote in an email, 'the only special interest guiding the Administration's decision-making is the best interest of the American people.' Tobacco-control advocates say Trump's early moves could undermine the country's progress diminishing smoking and the diseases it causes. 'These levels are decreasing because we have made such a commitment over the past few decades to enact things to work to get these levels down,' said Catharine Young, a Biden administration official who worked on his cancer moonshot initiative. 'But if you stop that or if you don't increase that effort, they're not going to continue to go down. They're either going to flat line, or they're going to start rising again.' Both Democratic and Republican administrations have hesitated to use all the regulatory authorities the 2009 law granted them. After Gottlieb resigned in March 2019, the agency's efforts to advance his 2017 tobacco plan were snuffed out. 'With his resignation, we lost the champion for the 2017 plan, and some months after he resigned, I was literally ordered by political appointees at FDA to stop talking publicly about menthol and nicotine,' said Mitch Zeller, who led the FDA's Center for Tobacco Products before King. Ultimately, Zeller wasn't able to implement a menthol ban or nicotine limits during any of the three administrations he served. During Biden's administration, then-FDA Commissioner Robert Califf enlisted allies outside the government to lobby the White House after agency efforts to ban menthol cigarettes were held up at the Office of Management and Budget. But the final rule was not published before Biden left office. 'They caved to political pressure from cigarette companies,' Zeller said. The FDA estimated the plan to limit nicotine levels in cigarettes proposed during the Biden administration would avert 4.3 million deaths and prevent 48 million youth and young adults from starting habitual cigarette smoking by the end of the century if implemented. And banning menthol cigarettes in the U.S. would cut 324,000 to 654,000 smoking-attributable deaths by 2060, according to modeling studies cited in the 2022 proposal. Luis Pinto, a spokesperson for Reynolds American, the maker of Lucky Strike, Camel and Newport cigarettes, said the company has not yet met with Trump's FDA commissioner, Marty Makary. Pinto said the company is opposed to a menthol cigarette ban because it believes there are 'more effective and sustainable ways to help adult smokers transition away from combustible cigarettes.' 'Rather than setting a nicotine standard, the focus should be on expanding access to a diverse and innovative portfolio of potentially reduced-risk products,' Pinto said. 'Tobacco harm reduction, not prohibition, is the most effective path forward in reducing the health impacts of smoking.' On Capitol Hill, Kennedy has rarely discussed tobacco despite his focus on preventing chronic disease, disappointing lawmakers like Durbin, the second ranking Democrat in the Senate. In an interview with POLITICO, Durbin emphasized the tobacco industry is still a threat to public health, especially as it markets more novel forms of nicotine exposure like vaping, which has become popular among younger Americans. 'The tobacco companies have not given up. Their basic approach is to addict children to their product, and so now they're using vaping and [other] devices to get … high schoolers in America addicted to forms of nicotine,' Durbin said, referring to Gottlieb as a hero. 'I just don't think you can credibly say you're addressing public health in America and ignore tobacco and vaping.' King, who's now with the Campaign for Tobacco-Free Kids, an anti-smoking group, is still hoping to convince Trump officials that going after tobacco needs to be part of the MAHA agenda. And he says he sees hope in the FDA's crackdown on illegal e-cigarettes, which he interprets as a sign the government is looking to snuff out unapproved vaping products. 'We have seen the decimation of tobacco control infrastructure,' King said. 'It's important you have the resources and the people.'
The Hill
2 hours ago
- The Hill
Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul
Former White House COVID-19 response coordinator Ashish Jha, who served under President Biden, criticized the decision by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to fire all 17 experts on the U.S. Centers for Disease Control and Prevention's (CDC) vaccine panel. Kennedy announced the decision in an op-ed for The Wall Street Journal Monday, saying, 'A clean sweep is needed to re-establish public confidence in vaccine science.' But in an interview with CNN's Wolf Blitzer, Jha pushed back against Kennedy's reasoning. 'Look what he said in his op-ed was a series of nonsense about a group of individuals, experts…who shape what vaccines, if any, are going to be available to the American people,' Jha said in the interview. 'So obviously this is very concerning,' he continued. 'We'll have to see who he appoints next. But this is a step in the wrong direction.' Jha said he is concerned about what the move foretells about the secretary's agenda on vaccines. Jha pointed to what he characterized as a lackluster response from the secretary to 'the worst measles outbreak of the last 25 years.' He also expressed concern about Kennedy raising questions about vaccines causing autism, which Jha dismissed and said was 'settled science.' 'Then you put this in the middle of all of that,' Jha said, referring to the vaccine panel sweep, 'and what you have is a pretty clear picture that what Secretary Kennedy is trying to do is make sure that vaccines are not readily available to Americans, not just for kids, for the elderly.' 'He could go pretty far with this move, and I really am worried about where we're headed,' Jha continued. He said he's particularly concerned about the effect Kennedy's move will have on kids and whether they will continue having access to certain vaccines in the future. 'Kids rely on vaccines. I'm worried about whether the next generation of kids are going to have access to polio vaccines and measles vaccines. That's where we're heading. That's what we have to push back against.' Kennedy said in his op-ed that he was removing every member of the panel to give the Trump administration an opportunity to appoint its own members. Kennedy has long accused ACIP members of having conflicts of interest, sparking concern among vaccine advocates that he would seek to install members who are far more skeptical of approving new vaccines. But Jha pushed back against criticism that the panel was all Biden-appointed experts, saying, 'When the Biden administration came in, almost all of the appointees had come from the first Trump administration.' 'That was fine because they were good people,' he said. 'They were experts. Right now, it's the same thing. The people he is firing are experts — like a nurse in Illinois who spent her entire career getting kids vaccinated, cancer doctors from Memorial Sloan Kettering — like these are really good people.' 'And generally, CDC has not worried about when were they appointed. The question is, are they good and are they conflict free.'
